Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Pipeline Analysis

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1737275

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1737275

Mitral Valve Diseases

PUBLISHED:
PAGES: 384 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Mitral Valve Diseases Market to Reach US$4.7 Billion by 2030

The global market for Mitral Valve Diseases estimated at US$3.1 Billion in the year 2024, is expected to reach US$4.7 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2024-2030. Mitral Valve Repair Treatment, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Mitral Valve Replacement Treatment segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$834.8 Million While China is Forecast to Grow at 11.7% CAGR

The Mitral Valve Diseases market in the U.S. is estimated at US$834.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 11.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Mitral Valve Diseases Market - Key Trends & Drivers Summarized

Why Are Mitral Valve Diseases Emerging as a Critical Focus in Global Cardiovascular Care?

Mitral valve diseases, encompassing both mitral regurgitation (MR) and mitral stenosis (MS), represent a significant burden in the global spectrum of cardiovascular disorders. The mitral valve-situated between the left atrium and left ventricle-regulates unidirectional blood flow through the heart. Any structural or functional abnormalities in this valve can result in regurgitation (leakage) or stenosis (narrowing), ultimately impairing cardiac output and contributing to symptoms such as fatigue, dyspnea, palpitations, and pulmonary hypertension. Left untreated, these disorders progress to congestive heart failure and increased mortality risk.

Aging populations, rising rates of hypertension and atrial fibrillation, and improved imaging diagnostics are contributing to the increased detection and prevalence of mitral valve diseases. In developed countries, degenerative MR associated with mitral valve prolapse is more common, whereas in lower-income settings, rheumatic mitral stenosis remains a persistent issue due to limited access to early treatment and preventive care. The clinical importance of timely identification and management is growing, particularly with expanding therapeutic options that now include minimally invasive surgical and transcatheter procedures.

How Are Diagnostic and Therapeutic Advancements Reshaping the Treatment Pathway for Mitral Valve Disorders?

The diagnostic landscape for mitral valve diseases has significantly improved with the widespread availability of transthoracic and transesophageal echocardiography, 3D imaging, and cardiac MRI. These tools allow accurate assessment of valvular anatomy, leaflet motion, chamber dimensions, and regurgitant volume, enabling earlier detection and classification of disease severity. Risk scoring systems and multi-parametric evaluations are now central to treatment planning, guiding decisions between watchful waiting, pharmacologic management, and interventional therapy.

Surgical repair or replacement has long been the standard of care for severe mitral valve disease, particularly for patients with preserved ventricular function. However, innovations in transcatheter mitral valve interventions (TMVI), such as MitraClip, PASCAL, and valve-in-ring/valve-in-mitral annular calcification (ViR/ViMAC) procedures, are transforming treatment for high-risk patients who are not candidates for open surgery. Advances in robotic-assisted repair, chordal replacement systems, and annuloplasty rings are improving procedural safety and outcomes. Pharmacological management remains important in earlier stages or for symptomatic relief in non-operable patients, with beta-blockers, diuretics, and anticoagulants being frequently employed.

Which Patient Segments and Geographic Markets Are Most Affected and Driving Care Demand?

Mitral valve diseases disproportionately affect the elderly, particularly individuals above 65 years of age, many of whom present with multiple comorbidities such as diabetes, hypertension, or ischemic heart disease. MR is more prevalent in developed economies where life expectancy and degenerative diseases dominate, while rheumatic MS continues to impact younger populations in parts of Africa, South Asia, and Latin America. Additionally, women are more frequently diagnosed with mitral valve prolapse, which may progress to regurgitation in older age.

North America and Western Europe dominate the market due to well-established cardiovascular infrastructure, reimbursement mechanisms, and high diagnostic penetration. These regions are also leading in TMVI adoption. Asia-Pacific is witnessing growing demand due to aging demographics, increasing procedural capacity, and rising awareness of structural heart disease. In emerging markets, public health campaigns, mobile diagnostic units, and rheumatic heart disease screening initiatives are helping expand access to care. These efforts are especially important in rural and underserved regions, where mitral diseases often go undiagnosed until advanced stages.

What Is Driving Long-Term Growth in the Global Mitral Valve Diseases Market?

The growth in the mitral valve diseases market is driven by rising disease incidence, technological progress in imaging and intervention, and the convergence of clinical innovation with demographic aging. Expansion of heart failure programs, structural heart clinics, and multidisciplinary heart teams is allowing earlier and more personalized treatment interventions. Increasing regulatory approvals and reimbursement coverage for TMVI devices are accelerating their use in both primary and secondary MR cases.

Global clinical trials are expanding the evidence base for early intervention, particularly for functional MR associated with heart failure. Additionally, the development of transcatheter mitral valve replacement (TMVR) devices is unlocking new frontiers in treating anatomically complex or previously inoperable patients. Patient-centric innovations-including same-day discharge protocols, real-time monitoring, and telecardiology follow-ups-are improving long-term care delivery and reducing hospitalization costs.

As cardiology shifts toward preventative, less invasive, and outcomes-focused models, mitral valve disease management is set to remain a cornerstone of cardiovascular innovation and clinical investment-balancing quality of life, procedural safety, and healthcare economics.

SCOPE OF STUDY:

The report analyzes the Mitral Valve Diseases market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy, Mitral Valve Therapeutics); Indication (Mitral Valve Stenosis, Mitral Valve Prolapse, Mitral Valve Regurgitation); End-User (Hospitals, Ambulatory Surgery Centers, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • 4C Medical Technologies
  • Abbott Laboratories
  • Affluent Medical
  • Anteris Technologies
  • Artivion, Inc.
  • Bayer AG
  • Boston Scientific Corporation
  • Braile Biomedica
  • Cadrenal Therapeutics, Inc.
  • Colibri Heart Valve LLC
  • Corcym UK Limited
  • Edwards Lifesciences Corporation
  • HighLife Medical
  • Labcor Laboratorios Ltda
  • Lepu Medical Technology Co., Ltd.
  • LivaNova PLC
  • Medtronic plc
  • Micro Interventional Devices, Inc.
  • Novartis AG
  • Zydus Lifesciences Limited

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

Show more
Product Code: MCP34087

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Mitral Valve Diseases - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Degenerative and Functional Mitral Valve Diseases Drives Demand for Targeted Therapies
    • Expansion of Aging Global Population Throws the Spotlight on Age-Associated Mitral Regurgitation
    • Advancements in Non-Invasive Imaging Technologies Strengthen Early Diagnosis and Disease Monitoring
    • Growing Adoption of Minimally Invasive Valve Repair and Replacement Procedures Spurs Market Growth
    • Increased Use of Transcatheter Technologies Propels Innovation in Low-Risk Patient Interventions
    • Regulatory Approvals of TMVR Devices Accelerate Access to Novel Therapeutic Modalities
    • Integration of AI and 3D Echocardiography Enhances Accuracy in Mitral Valve Disease Assessment
    • Surge in Demand for Personalized Treatment Planning Drives Growth in Computational Modeling Applications
    • Rising Number of Structural Heart Disease Centers Expands Treatment Accessibility in Emerging Markets
    • Development of Next-Generation Annuloplasty Rings and Clip-Based Repair Devices Sustains Technological Advancements
    • Growing Clinical Evidence Supporting Valve-in-Valve and Valve-in-Ring Procedures Expands Physician Confidence
    • Collaborations Between Cardiology Societies and OEMs Strengthen Best Practice Guidelines for Intervention
    • Shifts Toward Early Intervention Strategies Propels Demand for Screening in Asymptomatic Populations
    • Global Growth in Cardiovascular Disease Awareness Campaigns Drives Preventive Diagnosis Efforts
    • Focus on Long-Term Outcomes and Patient-Reported Quality of Life Sustains Use of Durable Interventions
    • Increasing Investment in Regenerative Valve Research Opens New Frontiers for Biologic Therapies
    • Surge in High-Risk and Inoperable Patient Populations Fuels Demand for Transcatheter Access Routes
    • Improvements in Delivery System Profile and Device Flexibility Enhance Procedural Adoption
    • OEM Support for Surgeon Training and Clinical Education Accelerates Institutional Uptake
    • Reimbursement Expansion for Mitral Valve Procedures Drives Patient and Provider Willingness to Adopt
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Mitral Valve Diseases Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Mitral Valve Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Mitral Valve Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Mitral Valve Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Mitral Valve Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Mitral Valve Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Mitral Valve Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Mitral Valve Replacement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Mitral Valve Replacement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Mitral Valve Replacement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cardiac Resynchronization Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Cardiac Resynchronization Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Mitral Valve Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Mitral Valve Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Mitral Valve Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Mitral Valve Stenosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Mitral Valve Stenosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Mitral Valve Stenosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Mitral Valve Prolapse by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Mitral Valve Prolapse by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Mitral Valve Prolapse by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Mitral Valve Regurgitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Mitral Valve Regurgitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Mitral Valve Regurgitation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • JAPAN
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • CHINA
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • EUROPE
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Mitral Valve Diseases by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Mitral Valve Diseases by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Mitral Valve Diseases by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • FRANCE
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • GERMANY
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Mitral Valve Diseases by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Mitral Valve Diseases by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Mitral Valve Diseases by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • INDIA
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Mitral Valve Diseases by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Mitral Valve Diseases by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Mitral Valve Diseases by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Mitral Valve Diseases by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Mitral Valve Diseases by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Mitral Valve Diseases by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030
  • AFRICA
    • Mitral Valve Diseases Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Mitral Valve Diseases by Treatment Type - Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Mitral Valve Diseases by Treatment Type - Percentage Breakdown of Value Sales for Mitral Valve Repair, Mitral Valve Replacement, Cardiac Resynchronization Therapy and Mitral Valve Therapeutics for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Mitral Valve Diseases by End-user - Other End-Users, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Mitral Valve Diseases by End-user - Percentage Breakdown of Value Sales for Other End-Users, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Mitral Valve Diseases by Indication - Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Mitral Valve Diseases by Indication - Percentage Breakdown of Value Sales for Mitral Valve Stenosis, Mitral Valve Prolapse and Mitral Valve Regurgitation for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!